4.7 Article

Injection molding as a one-step process for the direct production of pharmaceutical dosage forms from primary powders

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 505, Issue 1-2, Pages 341-351

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ijpharm.2016.03.034

Keywords

Solid dispersion; Fenofibrate; Graft co-polymer; Hot melt extrusion; Injection molding; Direct powder processing

Funding

  1. Austrian Research Promotion Agency (FFG)
  2. ENGEL AUSTRIA GmbH
  3. BASF Germany

Ask authors/readers for more resources

The objective of the present study was to develop a one-step process for the production of tablets directly from primary powder by means of injection molding (IM), to create solid-dispersion based tablets. Fenofibrate was used as the model API, a polyvinyl caprolactame-polyvinyl acetate-polyethylene glycol graft co-polymer served as a matrix system. Formulations were injection-molded into tablets using state-of-the-art IM equipment. The resulting tablets were physico-chemically characterized and the drug release kinetics and mechanism were determined. Comparison tablets were produced, either directly from powder or from pre-processed pellets prepared via hot melt extrusion (HME). The content of the model drug in the formulations was 10% (w/w), 20% (w/w) and 30% (w/w), respectively. After 120 min, both powder-based and pellet-based injection-molded tablets exhibited a drug release of 60% independent of the processing route. Content uniformity analysis demonstrated that the model drug was homogeneously distributed. Moreover, analysis of single dose uniformity also revealed geometric drug homogeneity between tablets of one shot. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available